IIVS, in collaboration with Philip Morris International, recently presented data highlighting the predictive capability of in vitro assays in determining human response to non-burn tobacco products. Moreover, a ring trial of 6 independent laboratories has generated evidence that key events involved in human disease caused by nicotine-based products can be replicated using non-animal models. These results may increase interest in the use of alternative testing strategies for research and development and, eventually, regulatory acceptance. Read article.
The National Toxicology Program, in collaboration with other US federal agencies, has published a strategic roadmap offering a new framework for the safety testing of drugs & chemicals aimed at reducing the use of animals. Read more.
Recent news articles in the Washington Post and Bloomberg.com highlight China's efforts to move away from requiring animal testing of cosmetics, and the role of IIVS plays in providing much-needed training in alternative methods. Read more about our work in China.
Watch this new video that highlights our long standing collaboration with PISC to replace animal testing with innovative non-animal methods. We thank PISC for their long-time support. https://www.youtube.com/watch?v=nEfZOuIHslc&feature=youtu.be
IIVS President, Erin Hill, talked to Allure magazine about efforts to phase out animal testing of cosmetics in China and replace the practice with non-animal methods. The article, which appears in the November issue, examines that while animal testing is nearly non-existent in the U.S. and officially banned in the E.U., China’s regulatory agencies require animal testing of imported cosmetics and domestically manufactured ones, with some exceptions. Hill goes on to talk about the collaboration between IIVS and the Chinese government, citing the recently signed memorandum of understanding with the Chinese government on adopting non-animal test methods. Read the full article.
Eliminating animal testing is core to our mission. With the support of contributors like MAC Cosmetics, we are making real progress. Read this article in Teen Vogue that talks about our work and how companies like MAC Cosmetics are making a difference. Read article.
The PETA International Science Consortium (PISC) awarded four VITROCELL in vitro exposure systems to researchers from institutions in the UK, US, and Belgium who are leading the development of non-animal methods to test the toxicity of airborne substances. IIVS is grateful to PISC for donating the VITROCELL System for use in its new respiratory toxicology laboratory. The new lab provides non-animal testing services for evaluating potential respiratory hazards associated with novel ingredients and chemistries used in fragrances, personal care products, household and institutional cleaning products, and a wide range of traditional and emerging tobacco products. Read more.
Nominations are now being accepted for the 2017 Lush Prize. The annual prize rewards initiatives across science and campaigning that work to end or replace animal testing, particularly in the area of toxicology research. IIVS was honored to have received the first LUSH training prize in 2012. Watch our short video as IIVS President, Erin Hill, reflects on the award. Entries are being accepted for the categories of Science, Training and Young Researchers. Nominations close on Monday, July 24. Judges will meet in September to select the winning entries. Learn more.
The Canadian University of Windsor announces the opening of the Canadian Centre for Alternatives to Animal Methods , the first of its kind in the country. The center will work side-by-side with regulators, primarily Health Canada, and international consortia to expedite the development, validation, and acceptance of alternative toxicity testing methods in Canada. Read more.
A bill has been reintroduced in the US House of Representatives that would ban cosmetic animal testing and prohibit the sale of products tested on animals. The Humane Cosmetics Act (HR 2790) – like a similar measure considered in the last session of Congress – was introduced with broad bipartisan support. Read more.